BioCrude Technologies USA, Inc.: key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2025)
- -$197.4K
- Total Assets (FY2025)
- $11.0K
- Total Equity (FY2025)
- -$471.4K
- Cash Flows from Operating Activities (FY2025)
- -$161.4K
Source: BioCrude Technologies USA, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
